Next Innovative Therapeutics: Brazilian biotech developing drugs from national biodiversity for multifactorial diseases
| Date | Round | Amount |
|---|---|---|
| Dec 2024 | Funding round Brazilian biotech Nintx raised US$10M from investors including Fundo Pitanga, ECOA Capital, MOV Investimentos, Tiaraju and Adeste to accelerate its biodiversity-based drug research. | $10M |